FMP

FMP

Enter

ELOX - Eloxx Pharmaceutical...

Free Cash Flow of Eloxx Pharmaceuticals, Inc.(ELOX), Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribos

photo-url-https://financialmodelingprep.com/image-stock/ELOX.png

Eloxx Pharmaceuticals, Inc.

ELOX

NASDAQ

Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis patients with diagnosed nonsense mutations. The company also develops various preclinical programs for the treatment of alport syndrome, recessive dystrophic epidermolysis bullosa, junctional epidermolysis bullosa, and familial adenomatous polyposis, as well as various earlier discovery stage programs in oncology. Eloxx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Watertown, Massachusetts.

0.7 USD

0.0125 (1.79%)

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep